Mineral Oil
Softeners, Emollients
Sold as Hemorrhoidal · retaine MGD · Eyeleve MGD · Winco Hemorrhoidal · MAGNOLAX
- Drug class
- Softeners, Emollients
- Availability
- Over-the-counter
- Routes
- Oral, Ophthalmic, Rectal, Topical
- Markets covered
- 2
- Products on record
- 29
- FDA reports (12 mo)
- 237
Overview
Mineral Oil is an active pharmaceutical ingredient in the Softeners, Emollients group (A06AA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 14 | February 3, 2026 |
| CA Canada | Health Canada | 15 | March 13, 2026 |
USUnited States· FDA
14 products
Uses
Uses For use as a protectant against further irritation or to relieve dryness of the eye.
How to take
CACanada· Health Canada
15 products
15 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Drug interactions
Known interactions involving Mineral Oil. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 06f57d46-96c7-40… · revised January 15, 2026 [PDF]
- [2]Health Canada (DPD) · 00107875 · revised March 22, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.